Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem warned about Icy Hot

This article was originally published in The Tan Sheet

Executive Summary

FDA issues a warning letter to Chattem June 6 regarding misbranding of the company's Icy Hot Heat Therapy patches and inadequate procedures for implementing corrective action once the firm began receiving complaints about burns and skin damage linked to use of the product. The letter, sent by FDA's New Orleans District Office to Chattem President Robert Bosworth, details the lack of adequate directions for use and warnings on the product's labeling, and states Chattem failed to notify FDA of a labeling change instituted once consumer health risks emerged. The company also did not report in a timely fashion on complaints the patches caused injury. Chattanooga, Tenn.-based Chattem voluntarily recalled the Icy Hot Heat Therapy patches in February, six months after adding expanded warnings and precautions to the label (1"The Tan Sheet" Feb. 18, 2008, p. 5)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel